David Lazar, MD, is a board-certified ophthalmologist with subspecialty training in medical and surgical diseases of the retina. He serves the Southern California community from his practice, Lazar Retina, in West Los Angeles. This state-of-the-art facility mimics Dr. Lazar’s dedication to providing the best treatment available for conditions that affect eye health and threaten vision. He’s also firmly committed to providing personalized, patient-focused care in a warm and welcoming environment.
As a vitreoretinal specialist, Dr. Lazar is well-known for his surgical skill and expertise in diagnosing and treating issues that affect the retina and the vitreous body. He offers innovative procedures and therapies to diagnose and treat a range of eye conditions, including macular degeneration, macular holes, macular pucker, retinal tears and detachments, vein occlusions, posterior vitreous detachment, macular degeneration, and diabetic retinopathy.
Dr. Lazar was born and raised in Encino, California. He completed fellowship training in vitreoretinal diseases and surgery at the Lahey Hospital and Beth Israel Deaconess Hospital in Boston, Massachusetts. While there, he also served as Clinical Associate at Tufts University School of Medicine and Harvard Medical School.
Prior to his fellowship, Dr. Lazar was Chief Resident at the LSU/Ochsner Clinic Foundation program in New Orleans, Louisiana. During his time in New Orleans, he worked at the Veteran’s Affairs Hospital providing retina care for Veterans experiencing eye conditions associated with aging, including complications from diabetes and high blood pressure, macular degeneration, and retinal detachments.
Dr. Lazar has presented his research findings at several national meetings including: the American Society of Retina Specialists (ASRS), the American Association of Ophthalmic Oncologists and Pathologists (AAOP), the American Uveitis Society (AUS), and the Southern Medical Association (SMA).
Dr. Lazar currently serves as a co-investigator in several national clinical trials for the treatment of dry and wet macular degeneration. He’s also frequently asked to provide a second opinion regarding treatment options for serious eye conditions. His patients can rely on his medical expertise and reap the benefits of his patient-first approach to eye care.